Tricarballylic Acid

Tricarballylic Acid

SCHEMBL584043

CC(C(=O)O)C(C(=O)O)C(CC(=O)O)C(=O)O.O=C(O)CC(CC(=O)O)C(=O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.48
FOLH1 Q04609 3/20 0.41
CPA1 P15085 2/20 0.35
CPB1 P15086 1/20 0.35
CPA3 P15088 1/20 0.35
CPB2 Q96IY4 1/20 0.35
MME P08473 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
CHRM1 P11229 1/20 0.31
AKR1A1 P14550 1/20 0.31
CHRM3 P20309 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
ADRA1A P35348 1/20 0.31
HRH1 P35367 1/20 0.31
DRD3 P35462 1/20 0.31
SLC6A3 Q01959 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC2 Q92769 1/20 0.31
LTA4H P09960 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL259232 0.92 TDP1 (0.56) TDP1FOLH1SMN1; SMN2ADRA1ASLC1A3
SCHEMBL23060312 0.92 TDP1 (0.56) TDP1FOLH1SMN1; SMN2ADRA1ASLC1A3
SCHEMBL6631810 0.86 TDP1 (0.54) TDP1FOLH1SMN1; SMN2ADRA1ASLC1A3
SCHEMBL450856 0.77 TDP1 (0.65) TDP1FOLH1SMN1; SMN2ADRA1ASLC1A3
SCHEMBL3285462 0.76 TDP1 (0.72) TDP1FOLH1CPA1CPB1CPA3
SCHEMBL786389 0.76 TDP1 (0.72) TDP1FOLH1CPA1CPB1CPA3
SCHEMBL9643869 0.76 TDP1 (0.46) TDP1FOLH1CPA1CPB1CPA3
SCHEMBL25414620 0.74 TDP1 (0.68) TDP1FOLH1CPA1CPB1CPA3
Tricarballylic Acid SCHEMBL34866 0.73 FOLH1 (0.65) TDP1FOLH1CPA1CPB1CPA3
Tricarballylic Acid SCHEMBL1821947 0.73 FOLH1 (0.65) TDP1FOLH1CPA1CPB1CPA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2225272-B1 PEPTIDES DERIVED FROM NCAM (FGLS) ENKAM PHARMACEUTICALS AS (DK) 2015-10-21 EP disclosed
EP-1765861-B1 FGFR BINDING PEPTIDES ENKAM PHARMACEUTICALS AS (DK) 2012-02-15 EP disclosed
EP-2225272-A2 NOVEL PEPTIDES DERIVED FROM NCAM (FGLS) Enkam Pharmaceuticals A/S (DK) 2010-09-08 EP disclosed
EP-1660539-B1 COMPOUNDS COMPRISING LPA ENKAM PHARMACEUTICALS AS (DK) 2010-06-02 EP disclosed
WO-2009068042-A2 NOVEL PEPTIDES DERIVED FROM NCAM (FGLS) ENKAM PHARMACEUTICALS A/S (DK) 2009-06-04 WO disclosed
EP-1765861-A2 FGFR BINDING PEPTIDES Enkam Pharmaceuticals A/S (DK) 2007-03-28 EP disclosed
EP-1660539-A2 COMPOUNDS COMPRISING LPA Enkam Pharmaceuticals A/S (DK) 2006-05-31 EP disclosed
WO-2005014623-A9 COMPOUNDS COMPRISING LPA 2006-03-23 WO disclosed
WO-2005123759-A2 FGFR BINDING PEPTIDES ENKAM PHARMACEUTICALS A/S (DK) 2005-12-29 WO disclosed
WO-2005014623-A2 COMPOUNDS COMPRISING LPA ENKAM PHARMACEUTICALS A/S (DK) 2005-02-17 WO disclosed